rxstat › Shortages › Mumps Virus Live Attenuated Measles Varicella-zoster Rubella

Mumps Virus Live Attenuated Measles Varicella-zoster Rubella (Priorix-Tetra) shortage status

Shortage anticipated

Source: Health Canada shortage reports · Updated Jul 9, 2026

A shortage of Mumps Virus Live Attenuated Measles Varicella-zoster Rubella is anticipated but not yet confirmed. 1 product(s) have anticipated-shortage reports on file with Health Canada.

A vaccine used to help protect against measles, mumps, rubella, and chickenpox.

Products affected
0 / 1
Reports on file
5

Reports by product

The DIN is printed on your prescription label.

Anticipated
PRIORIX-TETRA
25118.9CCID50 1000CCID50 1995.2623PFU 1000CCID50 · POWDER FOR SOLUTION · GLAXOSMITHKLINE INC
DIN 02297884 · Disruption of the manufacture of the drug.
Resolved
PRIORIX-TETRA
25118.9CCID50 1000CCID50 1000CCID50 1995.2623CCID50 · POWDER FOR SOLUTION · GLAXOSMITHKLINE INC
DIN 02297884 · ended Jul 20, 2021 · Disruption of the manufacture of the drug.
Resolved
PRIORIX-TETRA
25118.9UNIT 1995.2623UNIT 1000UNIT 1000UNIT · POWDER FOR SOLUTION · GLAXOSMITHKLINE INC
DIN 02297884 · ended Jul 12, 2019 · Delay in supply of GSK Diluent (packs of 10s) required for use with vaccine. Alternate supply of GSK Diluent available in packs of 100.
Resolved
PRIORIX-TETRA
25118.9UNIT 1995.2623UNIT 1000UNIT 1000UNIT · POWDER FOR SOLUTION · GLAXOSMITHKLINE INC
DIN 02297884 · ended Jan 17, 2019 · Demand increase for the drug.
Resolved
PRIORIX-TETRA
25118.9UNIT 1995.2623UNIT 1000UNIT 1000UNIT · POWDER FOR SOLUTION · GLAXOSMITHKLINE INC
DIN 02297884 · ended Aug 21, 2018 · Delay in shipping of the drug.

What's happening

A manufacturer has told Health Canada it expects supply of Mumps Virus Live Attenuated Measles Varicella-zoster Rubella to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.

Mumps Virus Live Attenuated Measles Varicella-zoster Rubella is classified under “VIRAL VACCINES” (ATC J07BD).

Recent changes

Common questions

What is Mumps Virus Live Attenuated Measles Varicella-zoster Rubella used for?

A vaccine used to help protect against measles, mumps, rubella, and chickenpox.

When will Mumps Virus Live Attenuated Measles Varicella-zoster Rubella be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Mumps Virus Live Attenuated Measles Varicella-zoster Rubella in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (viral vaccines)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

*sarscov2 S-protein Mrna / 5'[m27 / 3'-ogppp (Comirnaty) No current shortage Chikungunya Virus Live-attenuated (Ixchiq) No current shortage Haemagglutinin-strain A B (Flulaval Tetra) No current shortage Hepatitis A Virus / Inactivated (Havrix) No current shortage Hepatitis B Surface Antigen (Engerix-B) No current shortage Inactivated Rabies Virus (Rabavert) No current shortage

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.